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Renal disease in pregnancy. l.A. Whitworth, D.K. Packham, K.F. 
Fairley, P. Kincaid-Smith, Department of Nephrology, The Royal 
Melbourne Hospital, Melbourne, Australia. Three hundred and ninety-
five pregnancies in 238 women with primary glomerulonephritis be-
tween 1962 and 1987 were analyzed. Twenty-six percent offetuses were 
lost, 24% were premature and 15% were small for gestational age. 
Maternal renal function deteriorated in 15% of pregnancies and 5% of 
the women failed to resolve post-partum. Hypertension occurred in 
52% of pregnancies, early in 26% and severe in 18%. Eighteen percent 
of the women who developed de novo hypertension in pregnancy had 
permanent hypertension post-partum. Proteinuria increased in 59% of 
pregnancies and was irreversible in 15% of women. Impaired renal 
function, early or severe hypertension and nephrotic proteinuria were 
significantly associated with increased fetal loss and prematurity. Fetal 
outcome and maternal complications were similar in patients with 
treated hypertension pre-pregnancy and those normotensive in the first 
trimester. 
Evaluation of the influence of the following factors: Hematuria, pro-
teinuria, blood pressure and initial renal function on the progress of 
glomerulonephritis during pregnancy. C.D. Potgieter, B. Van Rensburg, 
University of Pretoria, Pretoria, South Africa. The purpose of this 
study was to determine whether hematuria, proteinuria, blood pressure, 
and initial renal function had an adverse effect on glomerulonephritis 
during pregnancy. An adverse effect on glomerulonephritis was defined 
as a decrease in renal function. Methods: 1.) Fourteen patients with 
biopsy proven glomerulonephritis who became pregnant and for whom 
no immediate indication for termination was present were followed up 
before, during and after pregnancy. 2.) The following parameters were 
evaluated: clinical status, histology of glomerulonephritis, age, blood 
pressure, anti-hypertensive therapy, serum electrolytes, serum creati-
nine, glomerular filtration rate, urine microscopy, proteinuria and 
hematuria. Results: 1.) Successful pregnancies were obtained in all 14 
cases. 2.) Proteinuria increased during pregnancy in most patients as 
expected and didn't correlate with a decline in renal function. 3.) 
Hematuria didn't have any influence on the predictive value. 4.) Two 
cases eventually progressed to chronic renal failure, both of whom had 
had hypertension prior to gestation. 
Subtypes of acute post-infectious glomerulonephritis: A c1inico-patho-
logical correlation. c.L. Edelstein, W. Bates, Renal Unit, Tygerberg 
Hospital and Department of Anatomical Pathology, University of 
Stellenbosch, South Africa. The relationship between the histology of 
acute post-infectious glomerulonephritis (APGN) and the clinical pic-
ture is controversial. The case records and histology of 42 adults with 
the characteristic light and electron microscopic features of APGN 
were studied. The biopsies were divided into 3 subtypes depending on 
the distribution of subepithelial "humps" and other immune-complex 
deposits on electron. microscopy: The "starry sky", "garland" and 
"mesangial" patterns as described by Sorger. Immunofluorescence was 
available in 30 cases and showed predominant C3 and IgG staining. The 
degree of cellular proliferation and leukocytosis in the capillary lumens 
was highest in the earlier stages of the disease. The "mesangial" 
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pattern had a lesser degree of cellular proliferation and leukocytosis. 
There was no significant difference between the 3 subtypes with regard 
to age, hypertension, creatinine, anti-streptolysin 0 titer and low serum 
complement levels on presentation. Both the "garland" and "starry 
sky" subtypes had significantly more proteinuria than the "mesangial" 
subtype, but this was not statistically significant. Four of the 5 patients 
who had a crescentic nephritis, were of the "starry sky" subtype. Of 
the 6 patients who had a chronic course, all were of the "starry sky" 
group. In conclusion, our patients with APGN show a range of variation 
in the clinical and histological pictures. This variation is unrelated to the 
diverse infectious aetiologies. Besides the degree of proteinuria, and the 
chronic course of the "starry sky" subtype, no other clinical or 
etiological feature distinguishes the 3 different histological subgroups. 
Procoagulant activity of whole human glomeruli. R. van Zyl-Smit, 
Renal Unit, Groote Schuur Hospital, University of Cape Town, Cape 
Town, South Africa. A one-stage recalcification microassay was devel-
oped to accurately measure total procoagulant activity (PCA) of single 
glomeruli taken at the time of routine renal biopsy. The "tissue factor" 
nature of the procoagulant was demonstrated by its partial inhibition by 
phospholipase B and by the use of factor deficient sera. Arbitrary units 
were defined by reference to brain thromboplastin. Sixty-twO patients 
were studied. PCA ranged from 6 units in normal glomeruli to 214 units 
in some with focal necrotizing lesions. Glomerular volumes (x 106 JLm3) 
in these samples ranged from 1.6 (mean 2.7) to 8.44 (mean 5.2). Activity 
was expressed as unitslvol. Normal glomeruli had 8.3 U/vol (N = 6 so 
4.4). Those with focal necrosis and crescents 21 Ulvol (N = 9 so 5.7). 
Membranous nephropathy had significantly more than normals 13 U/vol 
(N = 9 so 3.2; P < 0.02); this was virtually identical to patients with 
active diffuse proliferative SLE 12.6 U/vol (N = 7 so 3.5), and similar 
to mesangial proliferative GN 16.5 U/vol (N = 8 so 6.9), low levels were 
noted in mesangiocapillarly GN 6 Ulvol (N = 6 so 3.2). Patients with 
SLE on long term steroids had reduced PCA 5 Ulvol (N = 5 so 2.5). 
Within each group studied PCA correlated well with severity of injury. 
The high levels noted in patients with membranous nephropathy 
suggest that the endothelial cells may be the major site' for PCA 
production. 
Experimental and clinical aspects of cyclosporine nephrotoxicity. P.A. 
Keown, British Columbia Transplant Society and University of British 
Columbia, Vancouver. Canada. Administration of immunosuppressive 
doses of CsA causes a fall in glomerular filtration rate (GFR), urine 
volume, and fractional excretion of sodium and potassium with conse-
quent hyperkalemia. With increasing doses, there is evidence of severe 
renal tubular injury. There is a nonlinear, kinetic relationship between 
the concentration of CsA in the blood compartment and renal dysfunc-
tion. An increase in CsA above the therapeutic range is followed within 
a period of 1 to 7 days by a subsequent rise in serum creatinine, which 
is responsive to a reduction in dose, and a return of the blood level to 
normal. The histological features of acute CsA nephrotoxicity, which 
are nonspecific, are confined predominantly to the tubular epithelial 
cell, and include the presence of giant mitochondria in the convoluted 
portion of the proximal tubule, isometric vacuolization in the straight 
portion of the proximal tubule, and tubular calcification occurring in 
foci of damaged tubules. Signs of tubular regeneration characterized by 
mitotic figures within the epithelial cells and irregularity of the tubular 
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lining are often observed. A marked discordance is frequently observed 
between these ultrastructural changes and functional effect of CsA, 
lending increasing support to the belief that proximal tubular modifica-
tions are not fundamental to the mechanism of action of this drug on the 
kidney. Chronic nephrotoxicity occurs in less than 10% of patients 
following renal transplantation, frequently in those grafts exposed to 
prolonged warm or cold ischemia and SUbjected to high levels of CsA 
post-transplant. There is a progressive though partially reversible renal 
function impairment with a decrease in renal plasma flow and metabolic 
acidosis with hyperkalemia. Histologically, fibrosis may adopt a striped 
or segmental distribution with tubular epithelial cell atrophy, thickening 
of both tubular and glomerular basement membrane, and glomerular 
changes of focal glomerular sclerosis. Vessels show medial sclerosis 
with narrowing of the lumen. 
Studies in the experimental animal demonstrate that CsA has a 
unique effect on the kidney, which is distinct from that of other known 
nephrotoxins. In the rat and dog, CsA causes an acute decrease in both 
cortical and medullary blood flow which is sustained throughout the 
duration of treatment and is rapidly reversed upon drug withdrawal, 
suggesting an acute alteration in glomerular capillary perfusion, al-
though recent studies have also implicated a contraction of the glomer-
ular mesangial cell. This effect appears to be systemic, and decreased 
perfusion also occurs in other organs, predominantly the pancreas, liver 
and lung, although it is not a ubiquitous feature. 
Considerable evidence now suggests that the afferent arteriolar 
vasoconstriction is mediated either by the products of arachidonic acid 
metabolism, or by a direct action of CsA on vascular smooth muscle. 
CsA causes a significant increase in both vasoconstrictor (TXAz) and 
vasodilatory (PGEz, PGIz) prostanoids, which immediately precedes 
the fall in renal blood flow and glomerular filtration. The administration 
of a selective inhibitor of thromboxane synthesis inhibits the rise in 
TXAz, and also completely eliminates the elevation in vasodilatory 
prostaglandins PGEz, suggesting that this is a compensatory response 
to CsA administration. Both this and other prostaglandin analogues 
produce a parallel significant improvement in renal flow and glomerular 
filtration. These observations are supported by studies from other 
investigators which indicate a similar increase in TXAz generation, and 
partial protection by TXAz blockade or the use of fish oil which alters 
the balance of prostanoid synthesis. CsA may also cause an increase in 
renal vascular resistance by a direct action on vascular smooth muscle 
or by endothelin release. CsA has been shown to increase the contrac-
tility of aortic rings in vitro, and to potentiate the increase in renal 
vascular resistance caused by noradrenalin in vivo. It is possible that 
reactivity of the vascular smooth muscle may be further amplified by 
the mild magnesium deficiency which accompanies CsA use, due to 
increased renal clearance of this molecule. The effect of CsA on 
vascular smooth muscle appears to be partially mediated through 
calcium dependent channels, and calcium channel inhibitors produce a 
significant improvement in renal blood flow and glomerular filtration in 
CsA treated animals without influencing the production of TXAz or 
other prostanoids. Although the pathogenesis of the progressive renal 
injury characterized by interstitial fibrosis remains unclear, two factors 
may be implicated. First CsA-triggered increased TXAz production and 
inhibition of endothelial PGIz production lead to enhanced platelet 
aggregation and the release of vasoactive substances including platelet-
derived growth factor which contribute to medial hypertrophy of the 
vessel wall with luminal narrowing. Second, the release of excited 
oxygen radicals in the vessel or ischemic interstitium may potentiate the 
vascular injury and the fibrotic reaction. Recent studies suggest that 
protection against excited oxygen radicals may alIJeliorate the early 
aspects of CsA-induced renal injury, but it is not known whether this 
will prevent the progressive destructive lesion caused by the drug. 
Rescue therapy with OKT3 in steroid-resistant allograft rejection. 
M.R. Moosa, C.L. Edelstein, W. Bates, Department of Medicine, 
University of Stellenbosch and Renal Unit, Tygerberg Hospital, South 
Africa. OKT3 is a powerful immunosuppressant which has been used in 
various ways in treating rejection in renal allograft recipients. We 
looked at the use of OKT3 in reversing rejection in patients unrespon-
sive to high dose methylprednisolone. OKT3 was administered daily to 
thirteen renal allograft recipients on standard triple antirejection ther-
apy. All, but two had biopsy proven rejection and had had at least two 
courses of high dose methylprednisolone. The patients were returned to 
their dry weights and given paracetamol, hydrocortisone and antihista-
mine before the first few doses of OKT3. The patients were monitored 
with regard to serum creatinine values, urine output and any reactions 
to the OKT3. Eleven out of the thirteen patients (85%) responded. 
Those treated within 90 days had better long-term graft survival than 
those treated later. Most patients had a first dose effect with fever, 
rigors, diarrhea. Serious infections was documented in 5 patients. Three 
patients receiving OKT3 have subsequently died, one of these most 
certainly as a direct consequence of OKT3 induced lymphoma compli-
cated by serious infections. Unusual complications that we noted were 
aseptic conjunctivitis (43%) and acute psychosis (15%). OKT3 is useful 
rescue therapy for resistant rejection, but at a price. 
Introduction of a computer based clinical management system for renal 
transplant patients. M. Pascoe, R. van Zyl-Smit, Renal Unit, Groote 
Schuur Hospital and Department of Medicine, University of Cape 
Town, Cape Town, South Africa. The sheer bulk of clinical data 
accumulated on renal transplant recipients is daunting, and appears to 
lend itself to computer based management. A joint venture between a 
number of interested groups developed such a system (TX) , based on an 
IBM (or compatible) micro-computer. Data from patients undergoing 
renal allografting after 111188 has been entered on the system. On 
30/4/90 data of 117 patients had been entered into the system. Individual 
patient data may be displayed either in graphic or text form, as a 
"Flow-chart". Data listings on groups of patients include a list of 
patients who died and listings of patients by sex blood group and tissue 
typing. TX can be used for day to day clinical management although 
data entry remains manual, since the flow charts generated can be 
stored in the folder and used in patient management. For data retrieval 
for research purposes TX will provide a useful data base once a larger 
number of cases has been entered. 
Renal transplantation with unrelated living donors in Natal. S. Na-
icker, I.P. Naiker, A.A. Haffejee, S. Dawood, Y.K. Seedat, Renal Unit, 
Addington Hospital and University of Natal, Durban, South Africa. 
The shortage of cadaver donors at our center led to the transplantation 
of kidneys from unrelated (UR) living donors in 1989. Variable results 
have been reported in this group. The aim of this study was to compare 
the results of renal transplantation from unrelated and related (R) living 
donors for the past 12 months. The case records of six unrelated and 
seven related donors were studied. One related donor transplant was 
excluded from this analysis because of technical failure in the early 
post-operative period. Results: 
Recipient age 
Donor 
Serum 
creatinine 
UR transplants 
34-54 (X44,17) 
Wife (N = 6) 
80-155 (X129) 
R transplants 
7-42 (x30,17) 
Mother (N = 2) 
Brother (N = 3) 
Sister (N = 1) 
60-170 (X125) 
Immunosuppression comprised low dose steroids, azathioprine and 
cyclosporin A. One patient from each group suffered acute rejection in 
the early post-transplant period, which was easily reversed by a course 
of intravenous steroids. In conclusion, this study was shown that renal 
transplantation with unrelated living donors is successful. Larger num-
bers are required to support this conclusion. 
Pediatric transplantation compliance study. K. Meyers, H. Weiland, 
P. Thomson, Pediatric Nephrology Department, Johannesburg Hospi-
tal, Johannesburg, South Africa. A total of 94 children were trans-
planted from 1984 to 1989 inclusive. Seventeen patients were excluded 
due to graft loss (2), death (2), oxalosis (2) and transfer to adults (10). 
Noncompliance (NC) was assessed as missed clinic visits plus medicine 
shortage, or admission ofNC. NC was found in 17 of 77 (22%),5 others 
were suspected ofNC. No colored or Asian pts were NC (N = 14). NC 
showed no correlation with parental marital status, sex or total lym-
phoid irradiation. Most NC was peripubertal (white 9.6 ± 2.5 yrs; black 
11.8 ± 1.6 yrs), with a smaller NC late teenager group. Social class 
correlated with NC, being lower (whites 2.8 vs. 2.3 and Africans 3.8 vs. 
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3.2) in NC pts. A total of 82.3% ofNC was from social class III plus IV, 
who formed 36 of63 (52.4%) ofpts (white plus African). NC social class 
II (3 of 26) vs. IV (12 of 24 was significant (P = 0.01). A total of 91.6% 
ofNC African pts are from social class IV. There were 12 of 25 (48%) 
African and 5 of 38 (13%) white NC pts (P < 0.01), but social class III 
plus IV white (3 of 12) vs. African (11 of21) failed to reach significance. 
(P < 0.1 > 0.05). Compliance (C) confirmation was sought on retro-
spective cyclosporin A (CsA) trough levels. Drugs and daily dosage 
were excluded as significant confounding variables: C N = 26; NC N = 
16. At CsA levels of <10, <20, <30 ng/ml C vs. NC values were P = 
0.0026, P =0.0251; P = 0.0253, respectively. CsA dosage was not 
significantly different. The NC pts were II Y2 times more likely to have 
a CsA level <10 ng/ml. NC patients have needed more grafts (P = 
0.037), have a shorter average graft survival, have lost more grafts (P = 
0.0003) and more have died (0.0197) than C pts. Summary: At least 20% 
of paediatric transplant patients are NC. Age (peripubertaJ) and lower 
social class are major factors, rather than race. NC was confirmed by 
low CsA trough levels. The problem needs urgent attention as NC 
adversely affects graft survival. 
Update on the pathophysiology of diabetic nephropathy. M.J. 
Schreiber, Continuous Ambulatory Peritoneal Dialysis Unit, Clinical 
Hypertension and Nephrology, The Cleveland Clinic Foundation, 
Cleveland, Ohio, USA. Diabetic nephropathy accounts for approxi-
mately 30% of all patients coming to end-stage renal disease (ESRD) in 
the United States and is anticipated to increase to 50% by the year 2000. 
Nearly one of every three patients with Type I (insulin dependent) 
diabetes develops nephropathy. There may be specific clues for the 
early recognition and appropriate therapy of nephropathy to slow the 
progression of disease. Elevated blood glucose may alter protein 
metabolism (eg. the glycosolation of hemoglobin (Hgb AI-C), within the 
glomerular basement membrane resulting in an increase in GBM size 
and alteration of sialoproteins and membrane charge. Other evidence 
suggests a role for overall renal growth and an increase in renal function 
early in the disease. There is little evidence to implicate immunologic 
injury in diabetic nephropathy currently. Detection of minute amounts 
of albumin utilizing sensitive RIA techniques during the pre-clinical 
stages of nephropathy appears to offer promise in predicting patients at 
risk. The presence of negligible amounts of microalbuminuria initially 
may be predictive of a low risk for subsequent nephropathy. By 
contrast, abnormal amounts of micro albuminuria (15 ILg/min) at presen-
tation may be highly suggestive of developing clinically significant 
nephropathy in the future. Several studies have drawn attention to the 
possible role of the genetic pre-disposition that hypertension may play 
in diabetic nephropathy. A significant chance bf nephropathy may 
occur with: a) a positive family history of hypertension; b) poor blood 
sugar control; c) higher blood pressure; d) abnormal sodium lithium 
counter transport in the red cell. Although hyperglycemia appears to be 
critical in initiating diabetic nephropathy recent studies attempting 
"tight" blood sugar control with either split dose therapy or the insulin 
pump demonstrates that maintenance of euglycemia may reverse the 
nephropathy after it has become clinically apparent. Furthermore, 
specific antihypertensive therapy may slow the progression of diabetic 
nephropathy (ACE inhibitors, calcium channel blockers, etc.). Obser-
vations in experimental models of diabetic nephropathy have greatly 
enhanced the understanding of the progression of diabetic renal disease 
from a hemodynamic perspective. It has been postulated that the 
elevation of glomerular pressure may damage and denude the GBM 
with transudation of proteins into the mesangium resulting in acute 
injury and subsequent glomerulosclerosis. The current interest is fo-
cused upon treating both systemic and glomerular hypertension and 
diabetic nephropathy. The effect of ACE inhibition treatment of hyper-
lipidemia and dietary protein restriction upon proteinuria and renal 
dysfunction are areas of current research. Potentially aggressive ther-
apy may retard the progression of nephropathy over time in patients 
who are identified to be predisposed to advancing kidney failure. 
Acute interstitial nephritis at Groote Schuur Hospital. B.L. Rayner, 
Renal Unit, Groote Schuur Hospital, Cape Town, South Africa. A 
retrospective study of all patients with biopsy proven acute interstitial 
nephritis (AIN) was undertaken to determine the clinical features, 
causes and outcome. Twenty-two patients, 16 male and 6 female (mean 
age 46 years), were identified from 1979 to date. Mean follow-up was 15 
months. Clinical presentation was varied with 4 patients reporting 
fever, 4 acute oliguria, 4 loin pain, and 3 skin rash. Six patients had no 
hematuria or proteinuria. The mean serum creatinine was 1130 ILmol/ 
liter and urea 42.4 mmol/liter, and 24-hour urinary protein 0.75 g. Two 
patients had eosinophilia, 4 jaundice, 12 significantly raised plasma 
LDH levels and 10 had renal enlargement on imaging. Histology 
showed severe changes in 15; moderate in 6; and mild in 1. The causes 
of AIN were definitely drug related in 10 (2 INH, 2 allopurinol, 5 
NSAID's and 1 phenolthalein), probably in 8 and unknown in 4. 
Recovery of renal function occurred in 13, partial in 5 and none in 4. 
Two died of complications of AIN. Fifteen patients received pulse 
steroids with 9 making a full recovery compared with 4 out of 7 not 
receiving steroids (NS). AIN has a similar presentation and outcome as 
reported elsewhere. Of interest is a high percentage with absent urine 
abnormalities and unexplained LDH elevations. 
Current state of the art of CAPD and future trends. M.J. Schreiber, 
Continuous Ambulatory Peritoneal Dialysis Unit, Clinical Hyperten-
sion and Nephrology, The Cleveland Clinic Foundation, Cleveland, 
Ohio, USA. CAPD has experienced a significant growth world wide 
over the last decade. Improved connectology and exchange system 
advances have dramatically decreased the peritonitis rate. Immuno-
modulator therapy may be indicated in specific patients with immune 
defects resulting in recurrent peritonitis. Biofilm formation and in-
creased adherence of bacteria to artificial material may provide a nidus 
for ongoing infection in certain individuals. Advances in catheter 
technology has demonstrated the importance of both placement and 
actual catheter design to be essential for optimal results. Currently, in 
the majority of patients with peritoneal dialysis catheters, long term 
survival (>3 years) is achievable. Catheter exit site care and the 
importance of proper "break in" techniques have lowered exit site 
infection rates and post placement complications. Improved under-
standing of the molecular biology of mesothelial cells and the impact of 
secretory products in preserving the peritoneal membrane will add 
valuable information to the peritoneal field in the future. A peritoneal 
biopsy registry is attempting to correlate anatomical alterations with 
clinical findings. Through identifying abnormalities in membrane struc-
ture one may predict degree of success on peritoneal dialysis. Assessing 
adequacy of dialysis through specific clinical tools such as the perito-
neal equilibration test (PET), ultrafiltration drain volume measure-
ments, KT/V urea, and total creatinine clearance (liters per week) has 
increasing applicability to patients in assessing treatment success. 
Further advancements in connectology, dialysis solution additives 
(amino acids, calcium, etc.), and cycler therapy (APD, tidal, high 
volume) offer the potential for increasing application of peritoneal 
dialysis to all patient groups. Questions regarding preservation of renal 
function with peritoneal compared to hemodialysis deserves further 
clarification; peritoneal dialysis may offer the potential for preserving 
residual renal function. 
Does isokinetic muscle strength predict physical working capacity in all 
patients on chronic hemodialysis? W. Diesel, C. Daniel, J. Felsher, G. 
Rogers, A. Meyers, L. Margolius, Department of Physiotherapy, 
Johannesburg Hospital, Johannesburg, South Africa. Patients with 
end-stage renal disease receiving chronic hemodialysis have impaired 
exercise tolerance. To establish whether this impairment is of either 
central cardiorespiratory or peripheral skeletal muscular origin, we 
measured exercise performance and peak oxygen consumption during 
maximal cycle ergometry in 35 patients receiving chronic hemodialysis. 
The sample was divided into 3 groups according to medication, group A 
were taking r-HuEPO (recombinant human erythropoeitin), group B 
were taking a beta blocker (AtenoloJ) and group C were taking neither. 
Skeletal muscle function was measured with a Cybex II isokinetic 
dynamometer. Peak rates of oxygen consumption (19.0 ± 1.8, 16.7 ± 
4.6 and 20.2 ± 5.2 (mean ± SD) ml O2 kg-I min-I). Peak blood lactate 
contrations (4.74 ± 1.57, 3.72 ± 0.98 and 4.55 ± 1.60 mmol . liter-I), 
peak heart rates (154 ± 16, 108 ± 20 and 152 ± 17 beats· min-I), peak 
rates of ventilation (67.9 ± 15.4, 59.5 ± 11.6 and 68.7 ± 20.7 
liter· min-I) and peak metabolic equivalents (4.9 ± 1.1,4.1 ± 1.0 and 
4.9 ± 1.5) were low in all groups, but respiratory exchange ratios (1.13 
± 0.08. 1.15 ± 0.09 and 1.14 ± 0.07) were compatible with maximal 
effort. All data expressed for groups A, Band C, respectively. There 
was no correlation between hemoglobin centration, total blood hemo-
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globin content or hematocrit and V02 peak, exercise duration, peak 
ventilation and peak blood lactate concentrations (P < 0.05) in all 
groups. However there was a significant correlation (P < 0.05) between 
isokinetic muscle strength and V02 peak, exercise duration and peak 
ventilation in group C. Therefore in renal dialysis patients not taking 
Atenolol or r-HuEPO, isokinetic muscle strength is a better predictor of 
exercise capacity than are variables determining blood oxygen carrying 
capacity. This suggests that the myopathy associated with chronic renal 
failure explains the impaired exercise tolerance of anemic patients with 
end-stage renal disease receiving chronic hemodialysis. 
Oral pentoxifylIine does not prevent hemodialysis induced neutropenia 
or hypoxemia. G. Thebus, B.L. Rayner, M.D. Pascoe, Renal Unit 
Groote Schuur Hospital, Cape Town, South Africa. The aim of the 
study was to determine if oral pentoxifylline prevents hemodialysis-
induced neutropenia or hypoxemia. Fifteen stable chronic hemodialysis 
patients underwent routine dialysis (control run). Bloods were taken for 
white blood count (WCC), p02 and pC02 at time 0, 20, 80, 140, and 200 
minutes via the arterial line. The procedure was repeated at another 
routine dialysis session 2 hours after oral ingestion of pentoxifylline 400 
mg. Cuprophane or cellulose acetate membranes were only used and 
not interchanged. Serum was stored at time 0 on the drug run for 
pentoxifylline levels. Results were analyzed using the analysis of 
variance. During the control run there was a highly significant drop in 
WCC and p02 (P < 0.005 and P < 0.001, respectively) especially 
marked at 20 minutes. pC02 levels remained constant. A similar trend 
was noted during the drug run and there was no statistical difference 
between the two. In conclusion oral pentoxifylline (400 mg) taken 2 
hours before dialysis does not prevent neutropaenia or hypoxemia. 
Drug levels are awaited before considering using intravenous pentoxi-
fylline. 
Melatonin status in chronic renal failure. M. Viljoen, M.E. Steyn, 
B. W.J. van Rensburg, L.S. Venter, C.D. Potgieter, J.J. Theron, 
Department of Physiology and Internal Medicine, University of Preto-
ria, Pretoria, South Africa. The study was initiated in order to deter-
mine the plasma levels of melatonin and to assess the circ:J.dian 
secretory activity of the pineal gland in chronic renal failure (CRF) and 
in patients with functional renal grafts. Melatonin plasma levels were 
determined in a group of white control subjects (Cw; N = 20), a group 
of black control subjects (CB; N = 20), in three groups of white CRF 
patients on conservative treatment (CTw; N = 30), maintenance 
haemodialysis treatment (MHTw; N = 30), and peritoneal dialysis 
(PDw; N = 20), respectively, in three groups of black CRF patients on 
conservative (CTB; N = 20), maintenance haemodialysis treatment (MHTB; N = 25), and peritoneal dialysis (PDB; N = 20), respectively, 
in a group of white patients with functional renal grafts (Txw; N = 40) 
and in a group of black patients with functional renal grafts (TxB; N = 
20). Circadian rhythms of melatonin secretion were examined in white 
CRF patients on MHT (N = 10), in white CRF patients after renal 
transplantation (N = 13) and in control subjects (N = 10). RIA analyses 
were applied. Melatonin levels were increased in all groups of CRF 
patients. No significant differences were found between Cw and CB, 
CTw and CTB, HDw and HDB, CTw and PDw, PDwand HDw, CTB 
and TXB or between PDB and TxB. Significant differences were found 
between renal patients and controls between CTw and Cw (P < 0.0001), 
PDw and Cw (P < 0.0001), HDw and Cw (P < 0.0001), Txw and Cw (P 
< 0.008), CT Band CB (P < 0.0001), PDB and CB (P < 0.0001), HDB and 
CB (P < 0.0001), TXB and CB (P < 0.0001). Racial differences were seen 
between PDw and PDB (P < 0.0044) and between Txw and TXB (P < 
0.0001). Circadian rhythms were absent in CRF patients and did not 
reappear after successful renal transplantation. 
Evaluation of melatonin in the infertility and sleep disturbances of 
hemodialysis-A pilot study. B. W.J. van Rensburg, M. Viljoen, M. 
Steyn, A. Smit, W.J.H. Vermaak, C.D. Potgieter, Departments of 
Internal Medicine, Physiology and Chemical Pathology, University of 
Pretoria, Pretoria, South Africa. A pilot study was conducted to assess 
the possible clinical significance of elevated S-Melatonin (M) levels in 
hemodialysis patients with regard to infertility and insomnia. Methods: 
a) Infertility: M were correlated with S-LH, FSH, prolactin, testoster-
one and sperrniograms in males (N = 11) and S-LH, FSH, prolactin, 
estradiol and progesterone in females (N = 6). b) Sleep: A questionnaire 
stating hours of sleep, episodes of awakening and excluding the effect of 
sedatives for one week was correlated with M. Results: a) Infertility: 
Hormonal changes previously described in renal failure were docu-
mented, but no statistically significant correlation could be found 
between M and any of the other parameters assessed. b) Sleep: An 
inverse relationship between M and average hours of sleep was found in 
females (N = 7, r = 0.92, P = 0.0025). Conclusions: Further evaluation 
with regard to M and S-LH in males as well as insomnia in females is 
warranted. 
Clinical and pathophysiological aspects of 132m amyloidosis. T.B. 
Driieke, Inserm Unit 90 & Department of Nephrology, Necker Hospi-
tal, Paris, France. Dialysis-induced amyloidosis of the Pz-microglob-
ulin (132m) type is a recently discovered complication of patients with 
chronic renal failure. In most instances, it is observed only after several 
years of renal replacement therapy by dialysis or related procedures. 
The first clinical manifestations are usually chronic, intermittent ar-
thralgias. With progression of the disease, chronic joint swelling, 
recurrent hemarthrosis and tenosynovitides of the finger flexors may 
occur, and destructive arthropathies eventually develop in at least part 
of the patients. Another prominent feature is the carpal tunnel syn-
drome with a prevalence of more than 80% in most series. The main 
X-ray features are subchondral bone cysts or articular erosions. Their 
incidence steadily increases with the prolongation of patient survival, as 
does that of the carpal tunnel syndrome, destructive anrthropathy and 
spondylarthropathy. In uremic patients, Pzm is retained in the circula-
tion and may reach extremely high plasma levels in anuric subjects. It 
is possible that the long-lasting, intermittent contact with dialysis-
related materials favors the occurrence and/or the velocity of progres-
sion of this syndrome. The respective role of chronic renal failure per 
se, dialysis-induced acute phase reactions (activation or generation of 
132m, complement, IL-l, TNF free oxygen radicals, proteases, etc.) and 
132m removal via dialysis has still to be elucidated. It is probable that the 
132m peptide, like other amyloidogenic proteins, must undergo proteo-
lysis in order to transform into the characteristic B-pleated fibril, 
together with the P component and glucoseaminoglycans. Finally, 
evidence is emerging that the 132m molecule is not an innocent by-
stander but that it has autocrine and/or paracrine properties (stimulation 
of IOF synthesis, of collagenase activity and of bone resorption), which 
could play an active role in the pathogenesis of dialysis-associated 
amyloidosis. 
Plasma and platelet fatty acid profiles of patients with chronic renal 
failure. B.P. Botha, F. Cloete, M. Kelderman, P.N. Badenhorst, A. du 
P. Heyns, MRC Blood Platelet Research Unit, Dept. of Haematology, 
U.O.F.S., Bloemfontein, South Africa. Platelet thromboxane A2 pro-
duction is decreased in uremic patients with prolonged bleeding times. 
The defect is proximal to the cyclo-oxigenase step in the metabolism of 
arachidonic acid (AA). AA is the precursor fatty acid in prostaglandin 
synthesis. An abnormal lipid profile may cause abnormalities in platelet 
function and may also accelerate atherosclerosis. We studied the fatty 
acid profiles in the plasma and platelets of patients with uremia 
complicated by prolonged bleeding times and in a normal control group. 
Four patients with renal failure and nine normal controls were investi-
gated. Serum cholesterol and trigliserides were measured routinely. 
Phospholipids were saponified and the resulting fatty acids methylated. 
The fatty acid methyl esters were identified and quantified by gas liquid 
chromatography. Results were expressed as nanograms of fatty acids 
per milliliter of plasma and in platelets as nanograms per 350 x 109/liter. 
Fifteen fatty acids were identified in platelets and in eleven statistically 
significant differences (P > 0.05) were found. Fourteen fatty acids were 
identified in the plasma and in seven statistically significant differences 
were found. The significance of the abnormal fatty acid profiles in the 
plasma and platelets of renal failure patients should be investigated 
further. 
The activity of arachinodyl COA synthetase in platelets of patients with 
chronic renal failure. B.P. Botha, F. Cloete, M. Kelderman, P.N. 
Badenhorst, A.du P. Heyns, MRC Blood Platelet Research Unit, Dept. 
of Haematology, U.O.F.S., Bloemfontein, South Africa. Prostaglan-
dins are important in normal platelet function. Studies have shown a 
decrease in thromboxane A2 production in platelets of patients with 
uremia complicated by prolonged bleeding times. This finding may be 
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important in explaining the thrombopathy of uremia. The defect in 
thromboxane production seems to be proximal to the cyclooxygenase 
step. Arachinodyl CoA synthetase is the long chain acyl CoA syn-
thetase that inserts arachidonic acid (AA) , in the Sn-2 position of 
phospholipids, in the platelet membrane. An abnormality in this step 
may well be the cause the decreased production of thromboxane A2 in 
uremia. We studied the production of 3H-phospholipids in the platelets 
of a normal controls (N = 6), and patients with uremia (N = 5). Platelets 
were isolated and incubated with different concentrations of 3H-AA 
(3.3-76.7 mM) and 3H-phosphatidyl-choline (PC) was measured with 
high performance liquid chromatography. Results were expressed as 
pmol PC formedimin/7.5 x 107 platelets. The double reciprocal plot of 
incorporation oflH-AA in PC of control platelets was linear, but not in 
uremic platelets . The ratios of PC formed at 7 and 11 nM arachidonic 
acid was 1.01 ± 0.034 in uremia and 0.54 ± 0.84 in controls. The 
difference was highly significant. (P < 0.00(1). The activity of arachi-
nodyl CoA synthetase is thus abnormal in platelets of patients with 
uremia. 
Phosphorylation of endogenous proteins in primate kidney: Effect of 
cyclic AMP. N.A. Whalley, K.D. Hammond, A.M. Meyers, Department 
of Medical Biochemistry, University of the Witwatersrand, Johannes-
burg, South Africa. The kidney is the target organ for a number of 
hormones which activate adenylate cyclase and hence cAMP depen-
dent kinases (PKA). The aim of this work was to study the protein 
substrates for PKA in membrane and cytosol of baboon and human 
kidney. Kidney cortex membrane and cytosol fractions were prepared 
by differential centrifugation. Fractions were incubated with and with-
out 10 fJ.M cAMP in the presence of [32Pl-ATP, and total protein 
phosphorylated was measured. Specific proteins phosphorylated were 
separated using denaturing gel electrophoresis and visualized by auto-
radiography. In baboon membranes a significant increase in total 
phosphate incorporation was seen in the presence of cAMP; in the 
cytosol there was no effect. Five bands of mass 46, 58, 82, 102 and 122 
kDa were intensified by cAMP in membranes. In cytosol, bands of mass 
56 and 66 kDa were intensified. Similar results were found in human 
kidney. Photoaffinity labelling using 8-azido-[32Pl-ATP indicated that 
the band of mass 56 kDa phosphorylated in cytosol may correspond to 
the regulatory subunit of PKA II: 
Effect of potassium citrate (K CIT) therapy on new calculi formation in 
recurrent stone formers (RSF) with hypocitraturia. N.A. Whalley, M.l. 
Sonnekus, A.M. Meyers, Metabolic Stone Unit, Johannesburg Hospi-
tal and Wits University, Johannesburg , South Africa. Citrate is one of 
the most important inhibitors of calcium calculus formation. The use of 
oral citrate therapy is controversial both from the potential hazards (i.e. 
urinary alkalinization) and efficacy aspects and few studies have ad-
dressed these issues. The aim of this prospective, but uncontrolled 
study was to determine the effects of K Cit therapy on calculi forma-
tion. One hundred and fourteenJ262 (44%) of pts were found to have 
hypocitraturia: 62 pts were lost to follow-up, 20 were excluded due to 
RTA and impaired renal function, and 9 are new cases; thus 22 pts were 
assessable. Pts were divided into Grp I-K Cit therapy alone (15 to 25 
mmoJ/day) N = 13, and Grp II-K Cit and other therapy N = 9, i.e. 
thiazide (N = 3), diet (N = 3) and orthophosphate (N = 3) . The mean 
follow-up period in both groups was 3.5 yrs. Urinary Cit mmoll24 hr 
was measured using the Boehringer Mannheim Citric Acid Kit. Normal 
excretion 3.44 ± .96 mmoll24 hr. The table summarizes results obtained 
pre- and post-Pot Cit therapy. 
Cit Vol 
mmol/24 hr literl24 hr 
pre post pre post 
Grp I 1.14a 2.52a 1.79 1.67 
±0.51 ±0.74 ±0.78 ±0.67 
Grp 11 1.29b 2.30b 1.88 1.82 
±0.47 ±0.53 ±0.49 ±0.68 
There was no significant increase in urine volume after attendance at 
stone clinic, thus this was not the reason for decreased stone formation. 
A significant increase in citrate mmoJ/24 hr and a decrease in calculi/yr 
pre 
0.69 a 
±0.38 
1.41 b 
±J.33 
Stones 
nolyr 
post 
0.08a 
±0.27 
0.15b 
±0.15 
a P < 0.005 
b P < 0.005 
Calcium 
mmoll24 hr 
pre post 
4.30 4.43 
±1.60 ±1.37 
6.92 5.32 
±2.98 ±2.17 
Oxalate 
fJ.n101124 hr 
pre post 
322 311 
±1l6 ±68 
334 276 
±1l2 ±101 
was found in both groups . There was no significant difference in urinary 
calcium mmoll24 hr or urinary oxalate fJ.mo1l24 hr in either Grp I or Grp 
II after K Cit therapy. Therefore, oral K Cit therapy by increasing 
urinary citrate levels results in chelation of Ca Ox, thereby significantly 
decreasing calculus formation in spite of an increase in urinary pH. 
The kidney and hypertension. J.A. Whitworth, Department of 
Nephrology, The Royal Melbourne Hospital, Melbourne, Australia. 
The association between hypertension and renal disease was recog-
nized by Bright in 1836. Hypertension is a common presentation of 
renal disease, and the latter may be missed unless the urine is carefully 
examined. As a general rule, the pressure of renal impairment or 
abnormal urine sediment in 'benign' hypertension means underlying 
renal disease. Hypertension causes renal failure through accelerated 
hypertension, or rarely, renal artery atheroma, and is a major factor in 
progression of underlying renal parenchymal disease. Volume is impor-
tant in the hypertension of end-stage renal failure and there is some 
evidence implicating a circulating inhibitor of Na-K ATPase. We have 
proposed that the hypertension of renal parenchymal disease is due to 
loss of activity of the enzyme 1I{:10H steroid dehydrogenase in the 
kidney, leading to a local excess of cortisol at the renal mineralocor-
ticoid receptor. 
Platelet cations and membrane ATPase activity in essential and malig-
nant hypertension in Black patients. R .M. Touyz, S. James, F.1. Milne, 
Department of Medicine, Wits Medical School, South Africa. Abnor-
mal cell membrane ion transport may be causally related to essential 
hypertension (EH). This association in malignant hypertension (MH) is 
unknown. Platelet membrane ATPase activity, serum and platelet 
cations were measured in normotensive (NT), EH and MH subjects . 
Methods: 50 black subjects were studied-25 NT, 17 untreated EH, 8 
MH (serum creatinine <200 fJ.mlliter). Serum and platelet Na+ , K+, 
MgH, CaH and platelet membrane Na+-K+-ATPase; CaH-ATPase 
and MgH-ATPase were determined. Results: The 3 groups were age 
matched. BP was significantly higher in the EH and MH groups 
compared to NT. Significant results were decreased serum and platelet 
Mg2+ and increased platelet CaH in EH and MH. Na+-K+-ATPase and 
Mg2+ -ATPase activities were depressed in EH. All 3 ATPases were 
inhibited in MH. Conclusions: In EH, hypomagnesemia may alter 
platelet membrane function, resulting in cytosolic hypercalcemia. In 
MH this 'membranopathy' is more severe. 
Altered cations and muscle ATPase activity in rat benign and malignant 
hypertension. R.M. Touyz, F.J. Milne , P.R. Marshall, Department of 
Medicine, Wits Medical School, South Africa. The role of cell mem-
brane function and cations in malignant hypertension (MH) is unknown. 
Cell membrane ATPase activity , and intra- and extracellular cations 
were measured in SHR with benign and MH. Methods: Male SHR were 
randomized at 10 weeks to control SHR (C; N = 49) and DOCA (30 
mg/kg/wk) salt SHR (DOCA; N = 70). Renal fibrinoid necrosis devel-
oped at 13 to 14 weeks of treatment in DOCA. Five DOCA and 3C were 
anaesthetized weekly; direct carotid BP was measured and blood 
collected. Serum (S), red blood cell (R), muscle (M) Na+, K+, MgH, 
CaH and striated muscle membrane ATPase (Na+-K+; MgH_; CaH _) 
activity were determined. Results : Three developmental phases were 
defined: benign (1-8 weeks of treatment), premalignant (9-12 weeks), 
MH (13-14). No significant differences occurred between groups in the 
benign phase. In the pre-malignant phase, significant results in DOCA 
were: raised BP, decreased SK +, SCaH , SMgH , RMgH, increased 
RCaH , MCa2+ and depressed activity of all 3 ATPases. In MH, DOCA 
had significantly raised RCaH , MCa2+ and low SMg2+ (P < 0.05) . 
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Conclusions: Decreased Mg2+ inhibits ATPase resulting in increased 
intracellular Ca2+, an important determinant of vascular contractility. 
Severe cellular Mg2+ and Ca2+ alterations may result in MH. 
The renal histopathology of essential malignant hypertension in Black 
South Africans. C. Isaacson, F.J. Milne, I. van Niekerk, M. Kenyon, 
D. V. Mzamane, Dept. Anatomical Pathology, SAIMR; Dept. Medi-
cine, Coronation Hospital; Dept. Medicine, Baragwanath Hospital, 
University of the Witwatersrand, South Africa. This study examines the 
renal histopathology of essential malignant hypertension in two groups 
of Black South Mricans. The first, an autopsy series, consists of 
material derived from the years 1956--1961, a period when adequate 
antihypertensive therapy had not yet become generally available. The 
second group, a renal biopsy series, was from an era when effective 
antihypertensive therapy was available (1979-1989). The study showed 
that the clinical and histopathological changes of malignant hyperten-
sion were similar in both the pre-treatment and treatment eras. Fibrin-
oid necrosis was found in 92% of the autopsy sections and 44% of the 
biopsies. While mucinous, onionskin and fibrotic changes of the blood 
vessels were commonly found, they were not invariably present and 
could not be considered the histopathological hallmark of malignant 
nephrosclerosis. It was often impossible histologically to distinguish 
malignant nephrosclerosis arising de novo from that superimposed on 
long standing, previously benign hypertension. Replication of the 
elastic which has been considered a marker oflong standing, previously 
benign hypertension, was a non-specific finding and was frequently 
observed in young hypertensives with a short clinical history. In the 
absence of fibrinoid necrosis a pathological diagnosis of malignant 
nephrosclerosis cannot be made with confidence in Black South Afri-
cans. 
Long-term follow-up of the hemolytic uremic syndrome of childhood. 
P.D. Thomson, K.E.C. Meyers, Division of Paediatric Nephrology, 
Dept. of Paediatrics, Univ. of the Witwatersrand and Johannesburg 
Hospital. Fifty-one patients of the 231 presenting with the hemolytic 
uremic syndrome between 1959 and 1989 (10 prior to 1970 and 41 after) 
were available for long-term follow-up (5 to 22 yrs). Just prior to 1970, 
a more intensive policy of management was commenced, including 
early dialysis in the severe (anuria> 48 hrs) cases, and the aqute and 
long-term mortality in the periods prior to and after 1970 were 24/83 and 
8/148, respectively (P = 0.00l), despite the mean ages being 0.72 ± 0.37 
(range 0.18 to 2.41) and 1.15 ± 1.46 (range 0.25 to 11.08) yrs (P = 
0.0009). The total group was classified as being mild (no anuria), Group 
A, or severe, and the latter was further subdivided into severe with 
anuria < 7 days (Group B) and anuria> 7 days (Group C). The clinical 
severity can be further delineated by 
Group B + 
Group A C P value 
Initial hypertension 46% 98% <0.01 
Seizures 11% 57% <0.01 
Mortality (acute 8/130 24/101 <0.00025 
and long-term) 
Calc. Creat. clear. 93.3 ± 24.5 58.7 ± 26.5 0.011 
mllminll.73 d 
with age (yrs) after 13.29 ± 4.11 15.5 ± 4.76 NS 
> 10 yr follow-up 
The 51 patients were analyzed as to whether they a) required long-term 
anti-hypertensive therapy, b) showed proteinuria> 1 g/liter, and c) calc. 
creat. clearance was <40 mIlminl1.73 m2, after at least 5 yrs follow-up. 
Group A 
Group B 
Group C 
(Mild) 
(anuria < 7 days) a 
(anuria> 7 days) b 
0117 
2/13 
9/21 
P = 0.0018 
a 1 with arteriolar involvement on biopsy and the other transplanted 
(but no initial biopsy) 
b 7 with arteriolar involvement on biopsy and 6 ofthese transplanted. 
The 7 transplanted patients have generally done well excepting for 1 
patient with 2 failed RLD transplants and who died on chronic hemo-
dialysis. Patients with the hemolytic uremic syndrome who are anuric 
for >48 hrs should have very long-term follow-up, particularly if the 
anuria lasts more than 7 days. Arteriolar involvement on biopsy 
predicts a poorer prognosis for hypertension, proteinuria and renal 
function. 
The New Zealand glomerulonephritis study: I. Introductory report 
with five year follow-up. R.R. Bailey, et. al. on behalf of The New 
Zealand Glomerulonephritis Study Group, New Zealand. Glomerulo-
nephritis (GN) is the most common cause of end-stage renal failure in 
New Zealand. From 1 July 1972 to 30 June 1983 all patients aged ~14 yr 
with biopsy-proven primary GN, were enrolled: a total of 803 patients 
from 84% of the population in this age group (75% of the 189,900 
Polynesians). All biopsy material was independently evaluated. The 
incidence of GN in men was more than twice (2.29) that in women, 
particularly for post-infectious GN (4.48), IgA nephropathy (3.58), 
anti-GBM antibody-initiated GN (3.36) and membranous nephropathy 
(3.18). Polynesians (predominantly Maoris) had a higher relative risk of 
GN than those of European descent (P < 0.001), particularly for MCGN 
(5.11), post-infectious GN (2.98), crescentic GN (2.75) and focal glo-
merulosclerosis (2.23), while IgA nephropathy was reduced in Polyne-
sians (relative risk 0.49). At 5 years 133 (16.6%) patients had entered a 
dialysis-transplant program and 39 (4.9%) had died from renal failure 
(notional renal death). Thirty-two (4.0%) further patients had died a 
non-renal death. The adjusted notional renal death rates at 5 years for 
the major GN subtypes were: crescentic GN 80%, MCGN 51%, 
anti-GBM/Goodpasture's 45.7%, FGS 26.4%, membranous nephrop-
athy 18.9%, and IgA nephropathy 16.5%. An adverse outcome, includ-
ing non-renal death was more frequent in Polynesians than non-
Polynesians (P = 0.0223). Follow-up will define the long-term outcome 
of patients in each histological category of GN and determine potential 
prognostic factors. 
Glomerulonephritis in Natal. Y.K. Seedat, K.B. Parag, B.C. Nathoo, 
S. Naicker, I.P. Naiker, Department of Medicine, University of Natal 
and King Edward VIII Hospital, Durban, South Africa. Glomerulone-
phritis in Southern Africa is characterized by a high frequency in 
Blacks, a lesser frequency in Indians and a low frequency in Whites. It 
differs from the rest of Sub-Saharan Africa by the absence of quartan 
malaria which has been incriminated in the aetiology of nephrotic 
syndrome. In a study of 356 patients with nephrotic syndrome (248 
Blacks, 83 Indians and 25 Whitesl'Mixed' Race) between 1982 and 
1989, mesangiocapillary glomerulonephritis occurred in 47% and mem-
branous glomerulonephritis in 25% of the Black patients. In the Indian 
population 'minimal' change occurred in 18%, followed by membranous 
glomerulonephritis in 16.9% and mesangiocapillary glomerulonephritis 
in 13%. IGA glomerulonephritis was rare in the Blacks whereas it 
occurs in other racial groups. Crescentic glomerulonephritis occurred in 
7% of the Blacks and post-streptococcal nephritis was the most 
common· etiological factor. The difference in histological picture has 
important therapeutic implications. The impact of a positive hepatitis 
surface antigen in the etiology of membranous glomerulonephritis 
negates the value of steroid therapy. In adults steroids and other 
cytotoxic drugs are effective only in the 'minimal' change group or 
glomerulonephritis due to systemic lupus erythematosus. 
Mesangiocapillary glomerulonephritis (MCGN) in NataI./.G.H. Ran-
deree, Y.K. Seedat, K.B. Parag, B.C. Nathoo, R. Ramsaroop, Depart-
ment of Medicine and Anatomical Pathology, University of Natal, 
Durban, South Africa. This study was done to outline the clinico-
pathological features and assess the prognostic factors in patients with 
biopsy proven MCGN. The hospital records of 40 adult Black patients 
with renal biopsy features of MCGN, admitted over a two year period 
ending December 1987, were studied. Biochemical, immunological and 
urinary profiles were analyzed. At presentation, 68% had nephrotic 
syndrome, 68% had impaired renal function (serum creatinine greater 
than 200 J.tmoIlliter) and 65% were hypertensive. The mean albumin 
excretion of the former group was 9.91 gl24 hrs ± SD 4.92 gl24 hrs. 
Mean serum creatinine of all patients was 341 J.tmoIlliter ± SD 455 
J.tmoIlliter (range 62 to 2377). Of the total number of biopsies performed 
during the two years under study. MCGN was found in 13%. In terms 
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of the primary glomerulonephritides this represented 25%. All 40 
patients had Type I features on light microscopy and immunofluores-
cence. MCGN represents the most common form of glomerulonephritis 
in our environment. In the majority of patients, at least one of the 
recognized poor prognostic factors was present on admission, that is, 
nephrotic syndrome, hypertension or elevated serum creatinine. 
Nephrotic syndrome in children at the Baragwanath and Johannesburg 
Hospitals. 1982-1988 Inclusive. U.K. Kala, D. w.e. Jacobs, K.E.C. 
Meyers, P.D. Thomson, Paediatric Nephrology, University of the 
Witwatersrand, Johannesburg and Baragwanath Hospitals. Johannes-
burg, South Africa. Pediatric patients (pts) presenting with nephrotic 
syndrome (305 in total) were retrospectively analyzed; Baragwanath 
(Bara) had 182 pts, Johannesburg (Jhb) 123 pts. They were analyzed for 
age of onset, disease type, number biopsied, diagnosis breakdown, 
particularly highlighting focal glomerulosclerosis (FGS). Nephrotic pts 
formed 15% of renal admissions at Bara and 11% at Jhb. Almost all 
were biopsied at Bara. Of those with minimal change (MCNS) at Jhb 
33/57 (68%) were biopsied as well as all other nephrotics. Within the 
disease categories seen at Bara versus Jhb: MCNS was 23% vs. 46% (P 
= 0.0001); (FGS 25% vs. 18%); membranous 12% vs. 3% (P = 0.006); 
mesangial 15% vs. 2%; MPGN 3% vs. 5%; others 22% vs. 26%. Bara 
has a higher membranous group associated with hepatitis B infection. 
The Bara MCNS are probably over reported (some are/or progress to 
FGS). Some "mesangial" diagnoses may have related to a higher acute 
post-streptococcal glomerulonephritis prevalence at Bara. MPGN was 
rare at both centers. Bara had a significant congenital group reported as 
"Alport varients" on histology. The FGS plus MCNS group formed 
54% of patients (166/305). FGS was more common in black children 
than in White/Black/Asians (P = 0.0001). FGS at Bara had a significant 
association with a positive PPD (P = 0.0016). Of patients with FGS 27% 
(18/67) have been transplanted. Summary: At Bara, FGS/MCNS/ 
mesangial + membranous/other each form 25% of the nephrotic pts 
seen. At Jhb MCNS forms ± 50% of pts seen. MPGN is rare in the 
populations served. Bara have a group of congenital nephrotics with an 
electron microscopic picture suggestive of Alport's syndrome. Biopsies 
are now not done at Bara if hepatitis B serology is positive. Significant 
number of FGS patients reach end-stage renal failure. 
The impact of tuberculosis on childhood nephrotic syndrome. U.K. 
Kala, L.S. Milner, D. W.C. Jacobs, P.D. Thomson, University of the 
Witwatersrand, Baragwanath and Johannesburg Hospitals, South Af-
rica. The occurrence offocal glomerulosclerosis (FSGS) in Black South 
African children at Baragwanath Hospital is 25 to 35%. Tuberculosis 
(TB) is a common infection and therefore frequently associated with 
FSGS. We analyzed its prevalence and some possible implications in 
FSGS. Methods: We analyzed all biopsy-proven FSGS and compared it 
to minimal lesion nephrotic syndrome (MLNS) as the control group, for 
evidence of TB. Serum albumin, cholesterol, triglyceride, creatinine, 
3rd and 4th components of complement (C3, C4) serum immunoglob-
ulins G, A and M were analyzed. Glomerular filtration rate (GFR) was 
calculated using transformation formulae on presentation and at the last 
follow-up or prior to dialysis and transplant were compared in FSGS 
with TB (FSGS-TB) and without TB (FSGS-non-TB). Results: We 
analyzed 40 children with FSGS with a mean age of 4.8 ± 2.6 years; 
male:female ratio was 1.4: I. TB was identified in 15 (37.5%) children 
with FSGS compared to 6% in MLNS and 5% of all paediatric 
admissions. After a mean follow-up of 2.5 yrs the FSGS-TB had a GFR 
of 66.4 ± 50.8 mllminll.73 m2 vs. 99.4 ± 38.4 mllmin/1.73 m2 in 
FSGS-non-TB (P < 0.05). Five children with FSGS-TB required 
dialysis and transplantation compared to one child without TB. Con-
clusion: There is a sixfold increase in prevalence of TB in Black 
children at Baragwanath with FSGS compared to those with MLNS. On 
follow-up there is a significant decrease in GFR and dialysis and 
transplantation is required earlier in FSGS-TB vs. FSGS-non-TB. 
Interferon alpha 2b therapy in hepatitis B virus associated glomerulo-
nephritis. R. Gilbert, J. Wiggelinkhuizen, Renal Service, Red Cross 
War Memorial Children's Hospital, Rondebosch, Cape Town, South 
Africa. Remission of hepatitis B associated glomerulonephritis in many 
cases follows spontaneous seroconversion to anti-e antibody positive. 
In an attempt to induce seroconversion, 3 children were primed with 
prednisolone in reducing dosage for 3 weeks, followed by interferon 
alpha2b 7.5 JJim2 subcutaneously 3 times weekly for 12 to 16 weeks. 
One patient had seroconverted to anti-e antibody positive 4 weeks, and 
e antigen cleared 8 weeks after the start of interferon therapy. This was 
associated with a decline in proteinuria and an increase in plasma 
albumin levels. The other 2 patients remained e antigen positive and 
anti-e antibody negative 16 weeks after the start of interferon therapy. 
A decrease in proteinuria occurred in one pati~nt. Side-effects included 
flu-like symptoms and, in one patient, a recurring vesicular rash on the 
extremities. Interferon alpha2b therapy for hepatitis B associated 
glomerulonephritis warrants further investigation. 
Alternate strategies in immunosuppression for organ transplantation. 
P.A. Keown, British Columbia Transplant Society and University of 
British Columbia, Vancouver, Canada. During the last decade, the 
molecular steps in antigen recognition and cell signaling have been more 
clearly defined, identifying the role of the immunoglobulin supergene 
family, the structure/function relationships of MHC products, the 
biochemical sequence of phosphorylation, calcium-dependence and 
isomerase activity and the role of adhesion molecules in high endothe-
lial venule binding and directed lymphocyte migration. The use of 
immunosuppression at clinical and experimental levels has also become 
more complex and specific. Four classes of agent are currently used in 
clinical immunosuppression: corticosteroids, stimulating trans cortin 
release and altering G-protein activity among other membrane and 
cytosolic actions; azathioprine, inhibiting inosinic acid and purine 
synthesis, with additional potential actions of its imidazole group; 
cyclosporine, causing stereospecific inhibition of cistrans isomerase 
activity in calcium-dependent activation signals; and anti-lymphocyte 
antibodies, targeting the antigen receptor, MHC products or other 
molecules on the cell surface. 
Although studies indicate that CsA monotherapy and dual therapy 
with prednisone provide effective immunosuppression with cadaveric 
graft survival exceeding 80%, more intensive combination and sequen-
tial therapy has been increasingly used in North America to enhance 
initial graft function and further reduce the incidence of rejection. Data 
from the multi-site use of induction ALG suggest superior graft out-
come, and the American multi-center trial OKT3 induction produced a 
significant reduction in rejection incidence during the first month 
post-transplant (18% vs. 50%) with excellent cadaveric graft survival of 
90%. Longer term benefit appears less clear, however, (total rejection 
incidence: 52.4 vs. 66.7%) and cost, viral infection, and risk of 
malignancy have emerged as significant considerations. 
In the 500 renal transplants performed in our center during the past 
three years (466 cadaver, 34 related) we have compared the use of triple 
and quadruple immunosuppressive regimens. Overall first cadaver graft 
survival was 89% at one year and 85% at 3 years, with a projected graft 
survival half-life of 16.2 years. In non-sensitized «60% PRA) first 
cadaver allograft recipients, post-transplant dialysis was significantly 
less common in the group receiving ALG (9% vs. 26%, P < 0.001), and 
median serum creatinine was significantly lower at one week (135 vs. 
208 tLmollliter, P < 0.001) to three months (133 vs. 159, P < 0.012) 
post-transplant. There was no significant difference at six and twelve 
months. There was no significant difference in acute rejection (43% vs. 
53%), clinical cytomegalovirus infection (6% both groups) or other 
serious infections (11% vs. 5%). There was no difference in patient or 
graft survival (89% vs. 87% 12 months). There was a clear increase in 
risk in individual subgroups, however. In patients greater than 55 years, 
ALG use was associated with a significant increase in incidence of 
infection (32% vs. 16%, P < 0.001) without improvement in graft 
survival (85.2% vs. 90.2%). Treatment of acute rejection with OKT3 in 
patients receiving induction ALG produced comparable response rates 
to those receiving triple therapy (initial response: 81% vs. 84%, 
re-rejection 43% vs. 53%), but an alarming risk of CMV infection and 
lymphoma (12% vs. 4%), including two cases of fulminant EBV-
associated Iymphoproliferative disease. From the viewpoint of costs/ 
utility and risklbenefit, quadruple immunosuppression may therefore be 
most effectively reserved for high-risk, multiple graft recipients. 
A variety of promising immunosuppressive agents are currently 
under investigation. Bioactive cyclic peptides include the macrolide-
derived FK506 and rapamycin, exhibiting similar molecular action to 
CsA in inhibiting transcription of the interleukin gene complex, al-
though the latter possesses additional actions in IL-2-mediated cell 
proliferation and acts synergistically with CsA. Mizoribine and 15-
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deoxyspergualin exhibit differing selective effects on cellular activation, 
and hybrid monoclonals targeting CD7, CD25 and other determinants 
are now entering clinical trial. Inhibition of the inflammatory cascade, 
the modulation of prostaglandin and ecosinoid synthesis by misopros-
tyl, enisoprost and calcium channel blockade are therapeutic targets of 
recent interest, which simultaneously mitigate CsA nephrotoxicity and 
may confer additional immunosuppressive benefit. It is p!,stulated that 
the combination of these agents producing specific site-directed immu-
nosuppression will become increasingly important. 
Lupus nephritis (LN); The outcome of Black patients treated at 
Hillbrow Hospital. S.H. James, G. Habicht, L.P. Margolius, A.M. 
Meyers, Department of Nephrology, Wits Medical School, South 
Africa. Twenty-six patients with LN seen over 54 months were ana-
lyzed assessing their response to therapy as wei! as several clinical and 
laboratory parameters. Patients were analyzed in 2 groups (gps), those 
treated with (N = 13) and without pulse cyclophosphamide (PC) (N = 
13). They were further subdivided into responders and non-responders. 
Survival was assessed. The groups were equally matched for age and 
sex. Six of the PC gp died at follow-up (FU) 24.3 ± 12.4 mos; 6 were 
alive at 23.3 ± 7.9 mos. One was lost to FU. Five in non-PC group were 
dead FU 21.4 ± 24.5 mos, 4 alive at 23.5 ± 19.7 mos. Four were lost to 
FU. Cause of death in PC gp was sepsis 5/6, and renal failure in non-PC 
gp 4/5. The following variables were not found to be statistically 
significant on presentation and at the end of the study period, mean 
arterial pressure, serum creatinine, creatinine clearance, 24-hour urine 
protein, C3 , C4 , ESR and CRP. Renal function was significantly 
impaired in the non-PC gp of patients who died. The outcome of Black 
LN patients was not affected by the use of PC. They had a higher 
mortality rate due to sepsis; although renal function was preserved. 
Low dose total lymphoid irradiation treatment of lupus nephritis. R. 
Lakier, S.H. James, P.D. Thomson, K.E.C. Meyers, L.S. Milner, 
University of the Witwatersrand, South Africa. Total lymphoid irradi-
ation (TLI) was used to treat 12 patients with SLE, most of whom had 
failed conventional therapy. Radiation used for these high risk patients 
was low dosage wide field. A dose of 8 Gy was given in 10 fractions of 
0.8Gy; ovaries, testes, kidneys and lungs were shielded. Patients were 
aged between 12 and 51 yrs (median 22) and all the 8 adult patients were 
Black. Ten patients were female. Duration of disease prior to TLI was 
19 to 3063 days (median 398). Follow-up after TLI ranged from 44 to 
1195 days (l,TIedian 242). Eleven patients showed an initial subjective 
response to radiation and 5 of these subsequently required less main-
tenance therapy and both renal function and lupus markers improved. 
One adult female died of sepsis during TLI. Three other adult females 
died of sepsis and one of a secondary hemophilia due to a factor VIII 
inhibitor. Results-Median (Number of patients): 
ESR mm/br 
C3 mgldl 
C4 mgldl 
ANF titer 
Creatinine clearance 
ml/min/J073 rr! 
Urine ptotein glliter 
Pre-TLI 
75 (II) 
35 (7) 
8.9 (7) 
1/640 (11) 
56 (11) 
1.78 (10) 
10 months post-TLI 
38 (9) 
82 (5) 
21 (5) 
11640 (11) 
45 (9)a 
0.76 (9) 
a The 4 pediatric patients, however, showed an improvement. 
Three patients showed progressive disease after an initial response to 
radiation and 4 (3 children)have maintained an objective improvement 
in condition for a period from 168 to 1195 days. Radiation was tolerated 
and early responses seen in these severe cases were encouraging, but 
the Black adult mortality rate was alarming (5/8). A randomized study 
is required to evaluate the role of TLI in lupus nephritis. 
Vesico-ureteric reflux and reflux nephropathy. R.R. Bailey, Depart-
ment of Nephrology, Christchurch Hospital, Christchurch, New 
Zealand. Primary vesico-un:teric reflux (VUR) is a common congenital 
abnormality (lateral ureteric ectopia) that may be inherited as an 
autosomal dominant trait. The end result of gross VUR is reflux 
nephropathy. In early life the most common clinical presentation of 
VUR is with a complicating urinary tract infection. However, there are 
several other ways that VUR or reflux nephropathy may present 
including hypertension, a syndrome mimicking pre-eclampsia, protein-
uria, renal failure, urinary calculi, loin pain, nocturnal enuresis, asso-
ciated with other congenital abnormalities, during fetal ultrasonography 
or family screening and as a coincidental finding. There is impressive 
evidence that infancy and early childhood is the critical period in the 
natural history of the renal scarring associated with VUR. Most of the 
renal damage occurs during this period and is directly related to the 
severity of the VUR and the presence of intrarenal reflux. A continuing 
debate concerns the precise role complicating urinary tract infections 
have in the pattern and severity of the renal parenchymal damage. 
There is still controversy as to whether sterile VUR can result in renal 
scarring. There is no doubt that VUR and intrarenal reflux are ideal 
mechanisms allowing pathogenic organisms to rapidly enter the renal 
parenchyma. Depending on the age at which the initial organ imaging of 
the urinary tract is undertaken, 15-60% of infants and children with a 
bacteriologically proven urinary tract infection will be shown to have 
some degree of VUR, and 8-13% of the total will have reflux nephrop-
athy. In this unit reflux nephropathy is responsible for 11% of patients 
entering our dialysis-transplant program, and half ofthose <16 years of 
age. Any infant or child should undergo urinary tract investigations 
following their first proven urinary tract infection. Several prospective 
studies are currently assessing what investigations are most appropriate 
and cost effective at a given age (such as, ultrasonography, DMSA 
scan, intravenous urography, voiding cystourethrography, radionuclide 
micturating cystography). Prospective studies are evaluating the effect 
of surgical versus non-surgical management of the severest grades of 
VUR in infants and children taking long-term antimicrobial prophy-
laxis. What is required is a reliable, non-invasive method of detecting 
gross VUR at birth. 
Precalyceal tubular ectasia (PTE): I. Clinical and biochemical abnor-
malitiesin 24 patients. A.M. Meyers, N. Whalley, M.I. Sonnekus, L.A. 
Margolius, Metabolic Stone Unit (MSU), Johannesburg Hospital and 
University of Witwatersrand, South Africa. PTE (medullary sponge 
kidney) occurs in 1% of unselected EUG's. The inheritance, clinical 
spectrum and pathogenesis of renal calculi (RC) are controversial. In 
addition, these factors have never been assessed according to radiolog-
ical grading. This prospective study addressed these issues in 24 
patients with PTE (l5'?s and 9cis) who were further subdivided into 
grade I (15) or grade II (9) according to the EUG appearance. Results 
were compared with 334 "idiopathic" stone formers and 34 age- and 
sex-matched controls selected at random from the 334. Full metabolic 
stone work-up was performed on all. Prevalence of PTE: total = 7% 
(':? s 13%; cis 2.7%). Mean age of diagnosis = 38 vs. 43 years in controls 
eNS). Delay to diagnosis = 8 years. RC were present in 19 (80%) with 
II family history of calculi in 14 (58%). No cases of hel11ihypertrophy 
were found. Body mass did not differ between grade I, grade II or 
controls. There were more patients with RC in grade I vs. II (P < 0.04), 
more urinary infections in grade II vs. I (P < 0.02), or controls (P < 
0.01), and more renal insufficiency and scarring in grade II vs. I (P < 
0.0006) or controls (P < 0.026). Renal tubular acidosis was found in 5 
grade I vs. 7 grade II (NS). There were no differences in UCa mmo1l24 
hour, FeNa, Ca, Ca++, Phos, PTH or 1 :25 (OHhD3 between the grades 
or controls. The Ca:Cr ratio was abnormal in 7 PTE (5 absorptive, 2 
renal) and 46/105 of the controls (NS). Infective calculi were only found 
in 1 of the PTE vs. 2 controls (NS). Thus the diagnosis of PTE as a 
cause of recurrent calculi is commonly missed, especially in females. 
RT A is frequently present. With more extensive disease (as assessed on 
EUG), there is a progressive decline in calculus formation with an 
increase in prevelance of females, complete RTA, UTI, renal dysfunc-
tion and scarring. The same spectrum and prevelance of other metabolic 
risk factors for recurrent stone formation (such as, hypercalciuria, hyper-
oxaluria, hypocitraturia) were present in PTE vs. controls. A familial 
inheritance was suggested in >50% which require further studies. 
Precalyceal tubular ectasia (PTE): II. Studies on renal acidification in 
24 patients. A.M. Meyers, N. Whalley, M.I. Sonnekus, L.A. Margolius. 
Metabolic Stone Unit, Johannesburg Hospital and University of Wit-
watersrand. South Africa. Renal tubular acidosis (RT A Type I) is well 
documented in PTE. However, the correlations between radiological 
grading versus the clinical and stone formation potential in PTE patients 
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with or without RTA have not been accurately documented, and none 
of the above information is available when the RT A is further subdi-
vided into partial (PRTA) or complete (CRTA). This study clarifies 
these issues as well as documenting some differences between patho-
physiological mechanisms of P vs. CRTA in general. Methods: As for 
part I of the study, additionally, baseline arterial blood gas and short 
acid load tests (where indicated) were performed in 24 PTE patients and 
in 22 age- and sex-matched stone controls. As the radiological grading 
increased, that is, "blush or streaking" (grade I) to "bunch of grapes" 
or nephrocalcinosis (grade Il), so did the clinical, stone and acid-base 
patterns alter. PRTA was more common in grade I and CRTA in grade 
II (P < 0.014). PRTA was more common in PTE pts than the total stone 
group (N = 334; P < 0.0001), supporting the fact that grade I PTE is not 
merely a variant of a normal EUG. Renal calculi (RC) were less 
common in CRTA than in PRTA or PTE without RTA (P < 0.02) but 
UTI and renal insufficiency were more common in CRT A patients (P < 
0.02 and < 0.02, respectively). GFR was ± normal in PRTA resulting in 
high NH4 secretion and metabolic compensation. GFR correlated with 
the normal, the measured actual bicarbonate (r = 0.77, P < 0.01), 
supporting the hypothesis that functional severity of distal RT A is 
dependant upon GFR. In conclusion, both P and CRT A in patients with 
PTE are common problems and form part of the clinical, stone 
formation potential and biochemical continuum governed by the radio-
logical grading. Many of the hitherto obscure mechanisms of RC 
formation in these patients have been elucidated by these 2 studies. 
Pediatric nephrology experience. Johannesburg and Baragwanath Hos· 
pitals. 1982-1988 Inclusive. K.E.C. Meyers, P.D. Thomson, D. W.C. 
Jacobs, U.K. Kala, Paediatric nephrology, University of Witwa-
tersrand, Johannesburg and Baragwanath Hospitals, South Africa. All 
pediatric nephrology patients (pts), 1982-1988 inclusive, at Bara and 
Jhb Hospitals were reviewed. Criteria analyzed are for age, chronicity, 
disease category, mortality and transplantation. Bara admitted 1208 pts, 
80% new; Jhb 1137 pts, 41% new; 3.8% and 8.8% of total admissions, 
respectively (P < 0.0001). Mortality rates are 6% (Bara) and 4.2% (Jhb). 
Septicemia, obstruction and toxic causes predominate at Bara; not all 
renal neonatal deaths are reported. At Jhb 46% of deaths are in 
neonates, who form only 10% ofthe service load (P < 0.0001). At Bara 
69.4% are under 5 years, while 56.8% are over 5 years at Jhb (P < 
0.0001). Striking differences in disease patterns are noted. Acute 
post-streptococcal glomerulonephritis (APSGN) forms 10.7/1000 pedi-
atric admissions at Bara and 2.511000 at Jhb. Moreover, APSGN forms 
1/3 of renal pts at Bara, and 1/30 at Jhb (P < 0.0001). The acute versus 
chronic renal failure ratio is 2: 1 at Bara and reversed at Jhb. More ARF 
is seen at Jhb (144 vs. 75 pts) because (i) greater neonatal inclusion (ii) 
hemolytic uremic syndrome (HUS). Sixty of 144 pts with ARF at Jhb 
(41.6%) had HUS, there were only 2 possible cases from Bara. Primary 
reflux nephropathy at Jhb 45/0 Bara (1 case in 1989; P < 0.00001). Prune 
Belly syndrome and posterior urethral valves (PUV) are seen more 
often among Bara renal admissions, but do not seem to have a greater 
prevalence in the population as a whole (P = O.S; P = 0.06, respective-
ly). Bara does more renal biopsies, as all nephrotics biopsied. Black 
children form 40 to SO% of transplanted children per year. Summary: 
Bara's mortality figures are squewed by a lack of neonatal data. 
APSGN forms a significant portion of Bara's workload. Jhb's higher 
readmission and average age reflects on the service. HUS is more 
common in White children. Primary reflux is rare in Black children. 
Chronic hemodialysis and transplantation are available to all children. 
Renal bone disease. T.B. Drueke, Dept. of Nephrology, Necker 
Hospital. Paris, France. Uremic patients undergoing long-term renal 
replacement treatment may develop a variety of bone lesions due to 
osteitis fibrosa, osteomalacia, adynamic bone disease, osteoporosis and 
132m amyloidosis. The prevalence of each particular type of osteopathy 
depends on many different factors including underlying nephropathy, 
age, sex, physical activity, duration of chronic renal failure, mode of 
dialysis or related procedures, as well as dietary and medical manage-
ment. Consequently, mixed-type bone lesions prevail in most instances 
whereas pure forms are exceptional. Clinical manifestations are usually 
not pathognomonic although spontaneous bone fractures are more 
frequently associated with osteomalacia or adynamic osteopathy, and 
severe pruritus with osteitis fibrosa. The assessment of combined 
biochemical, X-ray, scintigram, CT scan and MNR imaging parameters 
may allow to establish the diagnosis in predominant or pure types of 
osteopathy, but in most cases bone histomorphometry is required to 
obtain a precise diagnosis. It appears that the incidence of severe forms 
of osteitis fibrosa and osteomalacia has diminished during recent years. 
Changing treatment attitudes and promising new therapeutic ap-
proaches may help to further improve the clinical management of renal 
osteodystrophy. 
The role of phosphate in the pathogenesis of metabolic bone disease in 
chronic renal failure. J.M. Pettifor, Mineral Metabolism Research Unit, 
Department of Paediatrics, Baragwanath Hospital, South Africa. 
Chronic renal failure is characteristically associated with hyperparathy-
roidism. In the late 1960s, Bricker et al proposed that hyperphos-
phatemia due to impaired renal excretion led to hypocalcemia and a 
resultant increase in PTH secretion (the "trade off hypothesis"). More 
recently, studies have suggested that decreased 1,2S-dihydroxyvitamin 
D (1,2S(OH}zD) production plays a central role in the pathogenesis of 
hyperparathyroidism. Although a decrease in functional renal tissue 
might be responsible for reduced 1,2S(OH}zD in end-stage renal failure, 
this is not so in mild/moderate renal insufficiency. Early in renal failure, 
an alteration in the renal handling of phosphate (Pi), with a possible 
increase in renal intracellular Pi suppresses la-hydroxylase activity. A 
reduction in 1,2S(OH}zD levels has been shown to: I) alter the Ca set 
point of the parathyroid gland, 2) increase in preproPTH mRNA and 3) 
increase PTH secretion. Prevention of metabolic bone disease in 
chronic renal failure should start early in the progression of the disease 
with control of dietary Pi intake and possibly the early introduction of 
the la-hydroxylated analogues of vitamin D. 
Microvascular changes in chronic renal failure. K.I. Furman, J. 
Lewin, Department of Medicine, Division of Nephrology, University of 
the Witwatersrand, Johannesburg, South Africa. Thickening and con-
centric reduplication of the basal lamina, narrowing of lumens and 
swelling and degeneration of endothelial cells of microvessels in the 
skin and other organs have been described by several authors as being 
characteristic or even diagnostic of analgesic nephropathy, diabetes 
mellitus, hypertension, chronic peritoneal dialysis and porphyria. We 
have noted similar changes in biopsy and autopsy specimens of skin, 
kidney, ureter, bladder, muscle and peritoneum of patients with chronic 
renal failure due to causes other than the above-mentioned diseases. 
Similar features have also been observed in experimentally induced 
pyelonephritis and renal failure in rats. If anything, these microvascular 
changes would seem to correlate more closely with associated hyper-
parathyroidism than to any particular etiology of the chronic renal 
failure. 
Right index finger radiographic manifestations of secondary hyper-
parathyroidism and intact parathyroid hormone levels in patients on 
chronic hemodialysis. C.D. Potgieter, H. Mentis, Division of Nephrol-
ogy, Department of Medicine, University of Pretoria, Pretoria, South 
Africa. Subperiosteal resorption of bone which is regarded as the 
hallmark of hyperparathyroidism is first seen along the radial side of the 
middle phalanges. Can these changes be correlated to intact parathyroid 
hormone levels so that radiographic changes in the phalanges be used as 
an indicator of parathyroid hormone status? Methods: (1) The right 
index finger of patients on long-term hemodialysis were evaluated 
radiographically using mammographic film. (2) Intact parathyroid hor-
mone levels were determined at the same time. Results: No accurate 
correla.tion could be found between index finger radiographic changes 
intact parathyroid hormone levels, although all cases with a high score 
of radiographic evidence did have high levels of intact PTH. There were 
also cases with minimal score and elevated levels of PTH. Grossly 
elevated PTH levels always had radiographic changes. 
